KCC009
An inhibitor of TG2
Catalog Number | 42453 |
Alternative Name(s) | ERW1095B |
Research Area | Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Cell Cycle|G1||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Cell Biology|Cytoskeleton & Motor Proteins||Research Area|Immunology & Inflammation|Autoimmunity||Research Area|Neuroscience|Neurodegenerative Disorders|Multiple Sclerosis |
Molecular Formula | C21H22BrN3O5 |
CAS# | 744198-19-4 |
Purity | ≥98% |
Inchi | InChI=1S/C21H22BrN3O5/c22-19-11-17(30-25-19)12-23-20(27)18(10-14-6-8-16(26)9-7-14)24-21(28)29-13-15-4-2-1-3-5-15/h1-9,17-18,26H,10-13H2,(H,23,27)(H,24,28)/t17?,18-/m0/s1 |
Inchi Key | MRULUIQNANUWTK-ZVAWYAOSSA-N |
SMILES | O=C(N[C@@H](CC1=CC=C(O)C=C1)C(NCC2ON=C(Br)C2)=O)OCC3=CC=CC=C3 |
Size | 50 mg |
Supplier Page | https://www.caymanchem.com/product/42453 |